Chenshu Xu

1.0k total citations
31 papers, 834 citations indexed

About

Chenshu Xu is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Chenshu Xu has authored 31 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Chenshu Xu's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (9 papers) and Hormonal Regulation and Hypertension (8 papers). Chenshu Xu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (9 papers) and Hormonal Regulation and Hypertension (8 papers). Chenshu Xu collaborates with scholars based in China, United States and Hong Kong. Chenshu Xu's co-authors include Jeff L. Staudinger, Huichang Bi, Kristin Lichti-Kaiser, Min Huang, Gang Hu, Sridhar Mani, Arunima Biswas, Xiaomei Fan, Xinkun Wang and Yue Cui and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Chenshu Xu

31 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenshu Xu China 17 347 271 226 157 100 31 834
Jackie C. Bloomer United Kingdom 13 268 0.8× 261 1.0× 180 0.8× 68 0.4× 47 0.5× 20 751
Xiaoyan Pang China 18 224 0.6× 382 1.4× 122 0.5× 60 0.4× 71 0.7× 35 883
Jouko Uusitalo Finland 18 547 1.6× 350 1.3× 243 1.1× 65 0.4× 71 0.7× 23 1.1k
Kesavan Sabitha India 15 154 0.4× 388 1.4× 116 0.5× 164 1.0× 37 0.4× 34 1.1k
Aik Jiang Lau Singapore 18 445 1.3× 668 2.5× 109 0.5× 102 0.6× 84 0.8× 39 1.1k
Jenni Küblbeck Finland 16 225 0.6× 292 1.1× 110 0.5× 94 0.6× 117 1.2× 36 770
Jasminder Sahi United States 21 539 1.6× 379 1.4× 479 2.1× 76 0.5× 58 0.6× 44 1.3k
Anuradha Sehrawat United States 22 162 0.5× 607 2.2× 137 0.6× 58 0.4× 44 0.4× 46 1.1k

Countries citing papers authored by Chenshu Xu

Since Specialization
Citations

This map shows the geographic impact of Chenshu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenshu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenshu Xu more than expected).

Fields of papers citing papers by Chenshu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenshu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenshu Xu. The network helps show where Chenshu Xu may publish in the future.

Co-authorship network of co-authors of Chenshu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenshu Xu. A scholar is included among the top collaborators of Chenshu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenshu Xu. Chenshu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Qingqing, Jiaxin Cai, Jiao Liu, et al.. (2023). Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation. Bioorganic & Medicinal Chemistry. 97. 117542–117542. 3 indexed citations
2.
Shen, Xianhuan, Qing Chen, Wenzhou Li, et al.. (2022). Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism. Frontiers in Pharmacology. 13. 1037239–1037239. 8 indexed citations
3.
Fan, Xiaomei, Wenzhou Li, Bin Liu, et al.. (2020). Genetic Polymorphism of ADORA2A Is Associated With the Risk of Epilepsy and Predisposition to Neurologic Comorbidity in Chinese Southern Children. Frontiers in Neuroscience. 14. 590605–590605. 13 indexed citations
4.
Huang, Haifeng, Xianqian Li, Lixiang Zhai, et al.. (2020). Anti-inflammatory properties of uvaol on DSS-induced colitis and LPS-stimulated macrophages. Chinese Medicine. 15(1). 43–43. 41 indexed citations
5.
Lv, Le, et al.. (2020). Green Tea Polyphenols Protect against Acetaminophen‐Induced Liver Injury by Regulating the Drug Metabolizing Enzymes and Transporters. Evidence-based Complementary and Alternative Medicine. 2020(1). 2696432–2696432. 5 indexed citations
6.
Zeng, Xuezhen, Xi Li, Chenshu Xu, et al.. (2017). Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice. Acta Pharmaceutica Sinica B. 7(5). 583–592. 44 indexed citations
7.
Xu, Chenshu, Min Huang, & Huichang Bi. (2016). PXR- and CAR-mediated herbal effect on human diseases. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(9). 1121–1129. 18 indexed citations
8.
Sun, Haiyan, et al.. (2016). Suppression of Hepatic Cyp1a2 by Total Ginsenosides in Lipopolysaccharide-Treated Mice and Primary Mouse Hepatocytes. Journal of Agricultural and Food Chemistry. 64(11). 2386–2393. 9 indexed citations
9.
Tan, Huasen, Chenshu Xu, Hang Zeng, et al.. (2015). SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells. Journal of Pharmacological Sciences. 130(2). 66–71. 9 indexed citations
11.
Xu, Chenshu, Pei‐Yi Chen, Jinqing Hu, et al.. (2014). Development, validation, and application of a novel 7-day Caco-2 cell culture system. Journal of Pharmacological and Toxicological Methods. 70(2). 175–181. 27 indexed citations
12.
Xu, Chenshu, et al.. (2014). Effect of Eclipta prostrata on 11Beta‐Hydroxysteroid Dehydrogenase in Rat Liver and Kidney. Evidence-based Complementary and Alternative Medicine. 2014(1). 651053–651053. 6 indexed citations
13.
Deng, Rongrong, Chenshu Xu, Xiao Chen, et al.. (2014). Resveratrol Suppresses the Inducible Expression of CYP3A4 Through the Pregnane X Receptor. Journal of Pharmacological Sciences. 126(2). 146–154. 28 indexed citations
14.
Chen, Jie, et al.. (2013). Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2. European Journal of Pharmacology. 714(1-3). 105–111. 53 indexed citations
16.
Staudinger, Jeff L., Chenshu Xu, Arunima Biswas, & Sridhar Mani. (2011). Post-translational modification of pregnane x receptor. Pharmacological Research. 64(1). 4–10. 63 indexed citations
17.
Staudinger, Jeff L., Chenshu Xu, Yue Cui, & Curtis D. Klaassen. (2010). Nuclear receptor-mediated regulation of carboxylesterase expression and activity. Expert Opinion on Drug Metabolism & Toxicology. 6(3). 261–271. 57 indexed citations
18.
Lichti-Kaiser, Kristin, et al.. (2009). A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor Protein. Journal of Pharmacology and Experimental Therapeutics. 331(1). 65–76. 50 indexed citations
19.
Xu, Chenshu, Xinkun Wang, & Jeff L. Staudinger. (2009). Regulation of Tissue-Specific Carboxylesterase Expression by Pregnane X Receptor and Constitutive Androstane Receptor. Drug Metabolism and Disposition. 37(7). 1539–1547. 42 indexed citations
20.
Lichti-Kaiser, Kristin, Chenshu Xu, & Jeff L. Staudinger. (2009). Cyclic AMP-dependent Protein Kinase Signaling Modulates Pregnane x Receptor Activity in a Species-specific Manner. Journal of Biological Chemistry. 284(11). 6639–6649. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026